FDA moves to rehire medical device, food safety and other staffers fired days earlier
Barely a week after mass firings at the Food and Drug Administration, some probationary staffers received unexpected news ...
Disrupted US vaccine meetings could threaten timelines, access and transparency around shots
Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...
STAT4h
To fight for those with rare diseases, Trump must reform and modernize the FDA thoughtfully
With the right policies, advanced science, and strong leadership in government agencies, Donald Trump has the power to save ...
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
JD Supra19h
FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Modern Healthcare19h
GLP-1 compounding pharmacies sue FDA over shortage decision
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
manilatimes40m
Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration
In the United States, ONS-5010 / LYTENAVA™ (bevacizumab-vikg) is investigational.